Yoshikiyo Akasaka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yoshikiyo Akasaka has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Hideko Kiguchi
Department of Pathology, Tokyo‐Kita Social Infrance Hospital, Tokyo, Japan
4 shared publicationsShigeki Ishiguro
Department of Pathology, School of Medicine, Toho University, 5‐21‐16 Omori‐Nishi, Ohta‐City, Tokyo, 143‐8540, Japan
4 shared publicationsToshiharu Ishii
Department of Pathology, School of Medicine, Toho University, 5‐21‐16 Omori‐Nishi, Ohta‐City, Tokyo, 143‐8540, Japan
4 shared publicationsIchiro Ono
Department of Dermatology, Sapporo Medical University School of Medicine, S1W16, Chuo‐ku, Sapporo, 060‐8543, Japan
3 shared publicationsKinji Ito
Department of Pathology, School of Medicine, Toho University, 5‐21‐16 Omori‐Nishi, Ohta‐City, Tokyo, 143‐8540, Japan
3 shared publicationsRisa Imaizumi
Department of Plastic and Reconstructive Surgery, School of Medicine, Toho University, 5‐21‐16 Omori‐Nishi, Ohta‐City, Tokyo, 143‐8540, Japan
3 shared publications
Latest Publications
- 12 March 2010
- Published by Wiley in The Journal of Pathology
- Vol. 221 (3) , 285-299
The mechanisms underlying fibroblast apoptosis regulated by growth factors during wound healing
While investigating the mechanisms underlying cell death during wound healing processes, we uncovered the pro‐apoptotic effects of basic fibroblast growth factor (bFGF) on granulation tissue fibroblasts following pretreatment with transforming growth factor (TGF)‐β1 in vitro. bFGF induced caspse‐3 activation and apoptosis in TGF‐β1‐pretreated granulation tissue‐derived fibroblasts (GF‐1) following bFGF treatment for 48 and 96 h. In contrast, fibroblasts that had been treated in the same manner and that originated from the uninjured dermis did not display apoptosis, indicating that the mechanisms underlying apoptosis events in fibroblasts that originate from normal dermal and wound tissues differ. In this process, we also found that bFGF inhibited Akt phosphorylation at serine 473 and induced a rapid loss of phosphorylation of focal adhesion kinase (FAK) at tyrosine 397 in pretreated GF‐1 cells, an event that coincided with the dissociation of phosphorylated FAK from the focal adhesions. Therefore, inhibition of survival signals relayed via the disrupted focal adhesion structures and inactivated Akt following bFGF treatment may lead to apoptosis in GF‐1 cells pretreated with TGF‐β1. Pretreatment of GF‐1 with TGF‐β1 followed by the addition of bFGF resulted in significantly greater inhibition of phosphorylation of Akt and FAK compared to treatment with TGF‐β1 or bFGF alone. The combinatorial treatment also led to proteolysis of FAK and inhibition of FAK and Akt protein expression in GF‐1 cells. These findings demonstrated a significant role for the two cytokines in apoptosis of granulation tissue fibroblasts during wound healing. In vivo studies also confirmed a marked decline in phosphorylation and protein expression of Akt and FAK in bFGF‐injected skin wounds. These results led to the hypothesis that temporal activation of TGF‐β1 and bFGF at the injury site promotes apoptosis in granulation tissue fibroblasts, an event that is critical for the termination of proliferative granulation tissue formation. Copyright © 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
- 12 March 2010
- Published by Wiley in The Journal of Pathology
- Vol. 221 (3) , 285-299
The mechanisms underlying fibroblast apoptosis regulated by growth factors during wound healing
While investigating the mechanisms underlying cell death during wound healing processes, we uncovered the pro‐apoptotic effects of basic fibroblast growth factor (bFGF) on granulation tissue fibroblasts following pretreatment with transforming growth factor (TGF)‐β1 in vitro. bFGF induced caspse‐3 activation and apoptosis in TGF‐β1‐pretreated granulation tissue‐derived fibroblasts (GF‐1) following bFGF treatment for 48 and 96 h. In contrast, fibroblasts that had been treated in the same manner and that originated from the uninjured dermis did not display apoptosis, indicating that the mechanisms underlying apoptosis events in fibroblasts that originate from normal dermal and wound tissues differ. In this process, we also found that bFGF inhibited Akt phosphorylation at serine 473 and induced a rapid loss of phosphorylation of focal adhesion kinase (FAK) at tyrosine 397 in pretreated GF‐1 cells, an event that coincided with the dissociation of phosphorylated FAK from the focal adhesions. Therefore, inhibition of survival signals relayed via the disrupted focal adhesion structures and inactivated Akt following bFGF treatment may lead to apoptosis in GF‐1 cells pretreated with TGF‐β1. Pretreatment of GF‐1 with TGF‐β1 followed by the addition of bFGF resulted in significantly greater inhibition of phosphorylation of Akt and FAK compared to treatment with TGF‐β1 or bFGF alone. The combinatorial treatment also led to proteolysis of FAK and inhibition of FAK and Akt protein expression in GF‐1 cells. These findings demonstrated a significant role for the two cytokines in apoptosis of granulation tissue fibroblasts during wound healing. In vivo studies also confirmed a marked decline in phosphorylation and protein expression of Akt and FAK in bFGF‐injected skin wounds. These results led to the hypothesis that temporal activation of TGF‐β1 and bFGF at the injury site promotes apoptosis in granulation tissue fibroblasts, an event that is critical for the termination of proliferative granulation tissue formation. Copyright © 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
- 6 July 2009
- Published by Wiley in Wound Repair and Regeneration
- Vol. 17 (4) , 617-625
Basic fibroblast growth factor induces down‐regulation of α‐smooth muscle actin and reduction of myofibroblast areas in open skin wounds
To examine the effects of basic fibroblast growth factor (bFGF) on the inhibition of α‐smooth muscle actin (α‐SMA) expression in dermal fibroblasts, we have established two dermal myofibroblastic cell lines positive for α‐SMA (rat myofibroblasts [RMF] and rat myofibroblast‐like [RMFL] cells) and one fibroblastic cell line negative for α‐SMA (rat fibroblasts cells) as a model of fibroblast differentiation. In contrast to the increased expression of α‐SMA in RMF and RMFL cells, irrespective of transforming growth factor‐β1 treatment, bFGF induced a decrease in α‐SMA expression in the myofibroblastic cells and the reduced expression patterns of α‐SMA differed between cells, as demonstrated by Western blot and reverse transcription polymerase chain reaction analyses. Along with the inhibition of α‐SMA expression by bFGF, the RMF and RMFL cells also showed different activated expression of extracellular signal‐regulated kinase 1/2, suggesting the involvement of extracellular signal‐regulated kinase 1/2 activation in the down‐regulation of α‐SMA expression in myofibroblasts. Furthermore, an in vivo study demonstrated that bFGF administration markedly decreases the area that is positive for α‐SMA expression in the treated wounds after day 18. In contrast, bFGF administration significantly increased the number of terminal deoxynucleotidyl transferase (TdT)‐mediated dUTP nick‐end labeling (TUNEL) staining and α‐SMA‐positive cells at days 10 and 14, and reduced the double‐positive cells rapidly after day 18. Collectively, the current investigation identified bFGF as a potent stimulator for the reduction of the myofibroblastic area in vivo, presumably because of its effects on the down‐regulation of α‐SMA expression as well as rapid induction of apoptosis in myofibroblasts.
- 6 July 2009
- Published by Wiley in Wound Repair and Regeneration
- Vol. 17 (4) , 617-625
Basic fibroblast growth factor induces down‐regulation of α‐smooth muscle actin and reduction of myofibroblast areas in open skin wounds
To examine the effects of basic fibroblast growth factor (bFGF) on the inhibition of α‐smooth muscle actin (α‐SMA) expression in dermal fibroblasts, we have established two dermal myofibroblastic cell lines positive for α‐SMA (rat myofibroblasts [RMF] and rat myofibroblast‐like [RMFL] cells) and one fibroblastic cell line negative for α‐SMA (rat fibroblasts cells) as a model of fibroblast differentiation. In contrast to the increased expression of α‐SMA in RMF and RMFL cells, irrespective of transforming growth factor‐β1 treatment, bFGF induced a decrease in α‐SMA expression in the myofibroblastic cells and the reduced expression patterns of α‐SMA differed between cells, as demonstrated by Western blot and reverse transcription polymerase chain reaction analyses. Along with the inhibition of α‐SMA expression by bFGF, the RMF and RMFL cells also showed different activated expression of extracellular signal‐regulated kinase 1/2, suggesting the involvement of extracellular signal‐regulated kinase 1/2 activation in the down‐regulation of α‐SMA expression in myofibroblasts. Furthermore, an in vivo study demonstrated that bFGF administration markedly decreases the area that is positive for α‐SMA expression in the treated wounds after day 18. In contrast, bFGF administration significantly increased the number of terminal deoxynucleotidyl transferase (TdT)‐mediated dUTP nick‐end labeling (TUNEL) staining and α‐SMA‐positive cells at days 10 and 14, and reduced the double‐positive cells rapidly after day 18. Collectively, the current investigation identified bFGF as a potent stimulator for the reduction of the myofibroblastic area in vivo, presumably because of its effects on the down‐regulation of α‐SMA expression as well as rapid induction of apoptosis in myofibroblasts.
- 25 May 2007
- Published by Wiley in Wound Repair and Regeneration
- Vol. 15 (3) , 378-389
Basic fibroblast growth factor in an artificial dermis promotes apoptosis and inhibits expression of α‐smooth muscle actin, leading to reduction of wound contraction
To clarify the mechanisms underlying declines in wound contraction caused by basic fibroblast growth factor (bFGF) and the role of autologous fibroblasts in modulating wound healing, we have examined the expression of α‐smooth muscle actin (α‐SMA) and apoptosis in a model of wound healing using collagen sponges with and without bFGF (1 μg) and/or fibroblasts (1 × 106 cells/cm2) applied to experimentally produced full‐thickness skin wounds in rats (n=10 for each group). At 7 days postoperatively, wounds filled with a fibroblast‐seeded collagen sponge (fibroblast‐seeded group) displayed a greater area of collagen sponge and a smaller area of fibroblasts compared with control wounds filled with collagen sponge alone (control group). Therefore, seeding of fibroblasts in the dermal substitute might retard degradation of the collagen sponge, inhibiting fibroblast infiltration into the substitute. By day 14, wounds filled with bFGF‐treated collagen sponge without fibroblast seeding (bFGF group) displayed decreased α‐SMA expression and significantly increased apoptosis compared with other wounds. Double staining revealed that apoptosis in α‐SMA‐positive fibroblastic cells was significantly increased in the bFGF group, suggesting that bFGF treatment is a potent stimulator of myofibroblast apoptosis. Furthermore, morphometric analysis demonstrated the significant decrease in the level of wound contraction and the degree of mature collagen bundle formation in the bFGF group by day 42. The bFGF group also showed increased bFGF expression in macrophages by day 28. These results suggest that bFGF administration to an artificial dermis promotes apoptosis of α‐SMA‐positive fibroblastic cells and inhibits α‐SMA expression in the treated wound, thus reducing wound contraction.
- 25 May 2007
- Published by Wiley in Wound Repair and Regeneration
- Vol. 15 (3) , 378-389
Basic fibroblast growth factor in an artificial dermis promotes apoptosis and inhibits expression of α‐smooth muscle actin, leading to reduction of wound contraction
To clarify the mechanisms underlying declines in wound contraction caused by basic fibroblast growth factor (bFGF) and the role of autologous fibroblasts in modulating wound healing, we have examined the expression of α‐smooth muscle actin (α‐SMA) and apoptosis in a model of wound healing using collagen sponges with and without bFGF (1 μg) and/or fibroblasts (1 × 106 cells/cm2) applied to experimentally produced full‐thickness skin wounds in rats (n=10 for each group). At 7 days postoperatively, wounds filled with a fibroblast‐seeded collagen sponge (fibroblast‐seeded group) displayed a greater area of collagen sponge and a smaller area of fibroblasts compared with control wounds filled with collagen sponge alone (control group). Therefore, seeding of fibroblasts in the dermal substitute might retard degradation of the collagen sponge, inhibiting fibroblast infiltration into the substitute. By day 14, wounds filled with bFGF‐treated collagen sponge without fibroblast seeding (bFGF group) displayed decreased α‐SMA expression and significantly increased apoptosis compared with other wounds. Double staining revealed that apoptosis in α‐SMA‐positive fibroblastic cells was significantly increased in the bFGF group, suggesting that bFGF treatment is a potent stimulator of myofibroblast apoptosis. Furthermore, morphometric analysis demonstrated the significant decrease in the level of wound contraction and the degree of mature collagen bundle formation in the bFGF group by day 42. The bFGF group also showed increased bFGF expression in macrophages by day 28. These results suggest that bFGF administration to an artificial dermis promotes apoptosis of α‐SMA‐positive fibroblastic cells and inhibits α‐SMA expression in the treated wound, thus reducing wound contraction.
- Open Access
- 1 January 2007
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 127 (1) , 82-88
Significance of Lymphatic Invasion on Regional Lymph Node Metastasis in Early Gastric Cancer Using LYVE-1 Immunohistochemical Analysis
It has been reported that lymphatic invasion is a predictor for lymph node metastasis in early gastric cancer (EGC); however, it has been impossible to differentiate between lymphatic invasion and blood vessel invasion using current staining techniques. We studied the significance of lymphatic invasion on regional lymph node metastasis in EGC by using human lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) antibody, specific to lymphatic vessels, and von Willebrand factor (vWF) antibody, specific to the blood vessels, to clearly distinguish these vascular tissues. EGC tissues were obtained from 66 node-positive and 66 node-negative subjects and were matched by age and sex. These tissues were immunostained with antibodies against LYVE-1 and vWF. Multivariate logistic regression analysis demonstrated that lymphatic invasion was a significant independent predictor for regional lymph node metastasis (odds ratio, 4.667; P = .0094), whereas blood vessel invasion was not. Thus, lymphatic invasion identified by LYVE-1 antibody could predict the existence of regional lymph node metastasis in EGC.
- 1 January 2007
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 127 (1) , 82-88
Open AccessSignificance of Lymphatic Invasion on Regional Lymph Node Metastasis in Early Gastric Cancer Using LYVE-1 Immunohistochemical Analysis
It has been reported that lymphatic invasion is a predictor for lymph node metastasis in early gastric cancer (EGC); however, it has been impossible to differentiate between lymphatic invasion and blood vessel invasion using current staining techniques. We studied the significance of lymphatic invasion on regional lymph node metastasis in EGC by using human lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) antibody, specific to lymphatic vessels, and von Willebrand factor (vWF) antibody, specific to the blood vessels, to clearly distinguish these vascular tissues. EGC tissues were obtained from 66 node-positive and 66 node-negative subjects and were matched by age and sex. These tissues were immunostained with antibodies against LYVE-1 and vWF. Multivariate logistic regression analysis demonstrated that lymphatic invasion was a significant independent predictor for regional lymph node metastasis (odds ratio, 4.667; P = .0094), whereas blood vessel invasion was not. Thus, lymphatic invasion identified by LYVE-1 antibody could predict the existence of regional lymph node metastasis in EGC.
- 7 May 2004
- Published by Wiley in The Journal of Pathology
- Vol. 203 (2) , 710-720
Basic fibroblast growth factor promotes apoptosis and suppresses granulation tissue formation in acute incisional wounds
Cytokines are thought to play an important role in cellular loss and apoptosis during the repair of granulation tissue. In order to investigate the role of apoptosis following the administration of basic fibroblast growth factor (bFGF) to a wound, the present study examined the relationship between the degree of granulation tissue formation and the level of apoptosis in rat skin incisional wounds, following treatment with an intradermal injection of bFGF (0.1 µg and 1 µg per cm of wound). Histological assessment of the width of the wound tissue showed that the degree of granulation tissue in the 1 µg‐bFGF‐treated group had increased by day 7, but then subsequently diminished by days 14 and 28. The TUNEL index increased rapidly from day 1, peaking on day 7, with the index being higher in the 1 µg‐bFGF‐treated group on days 4, 7, and 14, when compared with a control group. In parallel with a marked increase in the TUNEL index over the first 14 days, the number of cells positive for vimentin and CD3 in the 1 µg‐bFGF‐treated wounds had decreased by day 14. The number of PCNA‐positive cells, an indicator of cell proliferation, peaked on day 4 in the bFGF‐treated wounds and then declined rapidly. On the basis of these results, it is suggested that the suppression of granulation tissue formation in bFGF‐treated wounds is mainly due to an early and persistent increase in apoptosis in the granulation tissue cells. The expression of both transforming growth factor (TGF)‐β1 and bFGF was also elevated in the bFGF‐treated wounds on days 4 and 7, suggesting that fibroblast apoptosis was induced by bFGF treatment. Unexpectedly, on day 28, the wound breaking strength was not reduced in the bFGF‐treated wounds. These results indicate that apoptosis regulation following bFGF administration to an incisional wound may lead effectively to granulation tissue formation and promote a scar‐less repair process. Copyright © 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
- 7 May 2004
- Published by Wiley in The Journal of Pathology
- Vol. 203 (2) , 710-720
Basic fibroblast growth factor promotes apoptosis and suppresses granulation tissue formation in acute incisional wounds
Cytokines are thought to play an important role in cellular loss and apoptosis during the repair of granulation tissue. In order to investigate the role of apoptosis following the administration of basic fibroblast growth factor (bFGF) to a wound, the present study examined the relationship between the degree of granulation tissue formation and the level of apoptosis in rat skin incisional wounds, following treatment with an intradermal injection of bFGF (0.1 µg and 1 µg per cm of wound). Histological assessment of the width of the wound tissue showed that the degree of granulation tissue in the 1 µg‐bFGF‐treated group had increased by day 7, but then subsequently diminished by days 14 and 28. The TUNEL index increased rapidly from day 1, peaking on day 7, with the index being higher in the 1 µg‐bFGF‐treated group on days 4, 7, and 14, when compared with a control group. In parallel with a marked increase in the TUNEL index over the first 14 days, the number of cells positive for vimentin and CD3 in the 1 µg‐bFGF‐treated wounds had decreased by day 14. The number of PCNA‐positive cells, an indicator of cell proliferation, peaked on day 4 in the bFGF‐treated wounds and then declined rapidly. On the basis of these results, it is suggested that the suppression of granulation tissue formation in bFGF‐treated wounds is mainly due to an early and persistent increase in apoptosis in the granulation tissue cells. The expression of both transforming growth factor (TGF)‐β1 and bFGF was also elevated in the bFGF‐treated wounds on days 4 and 7, suggesting that fibroblast apoptosis was induced by bFGF treatment. Unexpectedly, on day 28, the wound breaking strength was not reduced in the bFGF‐treated wounds. These results indicate that apoptosis regulation following bFGF administration to an incisional wound may lead effectively to granulation tissue formation and promote a scar‐less repair process. Copyright © 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
- 27 November 2000
- Published by Wiley in The Journal of Pathology
- Vol. 193 (3) , 408-414
The effect of myocardial bridging of the coronary artery on vasoactive agents and atherosclerosis localization
- 27 November 2000
- Published by Wiley in The Journal of Pathology
- Vol. 193 (3) , 408-414
The effect of myocardial bridging of the coronary artery on vasoactive agents and atherosclerosis localization
- 1 January 1999
- Published by The Japanese Society of Clinical Cytology in The Journal of the Japanese Society of Clinical Cytology
- Vol. 38 (5) , 467-471
Cytologic examination of LE cells in pleural fluid from a patient with CNS lupus erythematosus.
LE細胞試験は, 全身性エリテマトーデス (SLE) などの自己免疫疾患で抗核抗体であるLE因子を, 人為的方法で好中球の核と反応させ, 形成されたLE細胞を観察する方法である. 本来LE細胞はin vitzoでの反応であるため, 生体の体腔液などにおいて観察されることはきわめてまれである. 本症例は66歳の男性に発症した重症のSLEで, 精神神経症状を呈した中枢神経ループス (CNSループス) であり, 年齢・性別・初発症状などが非定型的であったが, 胸水の細胞診でLE細胞が観察されたことが, その後の検査・治療に有用であった. 患者検体の胸水では多数の好中球や反応性中皮による炎症所見があり, この中に多数のLE細胞がさまざまな形態で出現していた. 典型的なLE細胞以外に, 破砕したLE小体を貧食したLE細胞もみられ変性細胞と誤診断される可能性が考えられた. また, 好中球の小集塊の中では, 中心にLE小体を有するロゼットを見逃さないよう注意すべきである. 実際には細胞診での診断機会が非常に少ないLE細胞であるが, 検出できた場合には診断的意義が高いため, スクリーニングにも十分な注意を払う必要がある.
- 1 January 1999
- Published by The Japanese Society of Clinical Cytology in The Journal of the Japanese Society of Clinical Cytology
- Vol. 38 (5) , 467-471
Cytologic examination of LE cells in pleural fluid from a patient with CNS lupus erythematosus.
LE細胞試験は, 全身性エリテマトーデス (SLE) などの自己免疫疾患で抗核抗体であるLE因子を, 人為的方法で好中球の核と反応させ, 形成されたLE細胞を観察する方法である. 本来LE細胞はin vitzoでの反応であるため, 生体の体腔液などにおいて観察されることはきわめてまれである. 本症例は66歳の男性に発症した重症のSLEで, 精神神経症状を呈した中枢神経ループス (CNSループス) であり, 年齢・性別・初発症状などが非定型的であったが, 胸水の細胞診でLE細胞が観察されたことが, その後の検査・治療に有用であった. 患者検体の胸水では多数の好中球や反応性中皮による炎症所見があり, この中に多数のLE細胞がさまざまな形態で出現していた. 典型的なLE細胞以外に, 破砕したLE小体を貧食したLE細胞もみられ変性細胞と誤診断される可能性が考えられた. また, 好中球の小集塊の中では, 中心にLE小体を有するロゼットを見逃さないよう注意すべきである. 実際には細胞診での診断機会が非常に少ないLE細胞であるが, 検出できた場合には診断的意義が高いため, スクリーニングにも十分な注意を払う必要がある.